BioCentury | Sep 24, 2019
Financial News

Amphivena to expand clinical program, T cell engager pipeline with $62M series C

...and Nawton, as well as existing investors MPM, funds managed by Tekla Capital Management and Franklin Berger. Elizabeth...
BioCentury | May 25, 2018
Financial News

Rain raises $18M to advance tarloxotinib in NSCLC

...with participation from fellow new investors Perceptive Advisors, Auckland UniServices' Inventors Fund and FMB Research’s Franklin Berger...
BioCentury | May 21, 2018
Financial News

Rain raises $18M to advance tarloxotinib in NSCLC

...with participation from fellow new investors Perceptive Advisors, Auckland UniServices' Inventors Fund and FMB Research’s Franklin Berger...
BioCentury | Feb 17, 2017
Financial News

Applied Therapeutics completes venture financing

...undisclosed amount in a series A round with Alexandria Venture Investments, E Squared Capital Management, Franklin Berger...
BioCentury | Mar 31, 2014
Financial News

Kolltan completes venture financing

...completed: 3/26/14 Type: Venture financing Raised: $60 million Investors: Institutional investor; KLP Enterprises; Deerfield Management; Franklin Berger...
BioCentury | Mar 27, 2014
Financial News

Cancer play Kolltan raises $60 million in series D

...undisclosed institutional asset manager and existing investor KLP Enterprises. New investors, including Deerfield Management and Franklin Berger...
BioCentury | Oct 24, 2011
Finance

Highlights of weekly biotech stock moves

...lost CHF0.73 (16%). PDL BioPharma Inc. (NASDAQ:PDLI) gained $0.12 to $5.81 last week after retaining Franklin Berger...
BioCentury | Oct 24, 2011
Company News

PDL BioPharma other news

...PDL BioPharma Inc. (NASDAQ:PDLI), Incline Village, Nev. Business: Other PDL retained Franklin Berger and Evan Bedil as...
BioCentury | Oct 19, 2009
Company News

OxiGene, VaxGen deal

...deal, which is expected to close in 1Q10. Two of VaxGen's directors, Lori Rafield and Franklin Berger...
BioCentury | Jan 5, 2009
Finance

2009 Financial Markets Preview: Weathering (nuclear)winter

...deals. "All the debt deals are in the rear view mirror - they're done," said Franklin Berger...
Items per page:
1 - 10 of 92
BioCentury | Sep 24, 2019
Financial News

Amphivena to expand clinical program, T cell engager pipeline with $62M series C

...and Nawton, as well as existing investors MPM, funds managed by Tekla Capital Management and Franklin Berger. Elizabeth...
BioCentury | May 25, 2018
Financial News

Rain raises $18M to advance tarloxotinib in NSCLC

...with participation from fellow new investors Perceptive Advisors, Auckland UniServices' Inventors Fund and FMB Research’s Franklin Berger...
BioCentury | May 21, 2018
Financial News

Rain raises $18M to advance tarloxotinib in NSCLC

...with participation from fellow new investors Perceptive Advisors, Auckland UniServices' Inventors Fund and FMB Research’s Franklin Berger...
BioCentury | Feb 17, 2017
Financial News

Applied Therapeutics completes venture financing

...undisclosed amount in a series A round with Alexandria Venture Investments, E Squared Capital Management, Franklin Berger...
BioCentury | Mar 31, 2014
Financial News

Kolltan completes venture financing

...completed: 3/26/14 Type: Venture financing Raised: $60 million Investors: Institutional investor; KLP Enterprises; Deerfield Management; Franklin Berger...
BioCentury | Mar 27, 2014
Financial News

Cancer play Kolltan raises $60 million in series D

...undisclosed institutional asset manager and existing investor KLP Enterprises. New investors, including Deerfield Management and Franklin Berger...
BioCentury | Oct 24, 2011
Finance

Highlights of weekly biotech stock moves

...lost CHF0.73 (16%). PDL BioPharma Inc. (NASDAQ:PDLI) gained $0.12 to $5.81 last week after retaining Franklin Berger...
BioCentury | Oct 24, 2011
Company News

PDL BioPharma other news

...PDL BioPharma Inc. (NASDAQ:PDLI), Incline Village, Nev. Business: Other PDL retained Franklin Berger and Evan Bedil as...
BioCentury | Oct 19, 2009
Company News

OxiGene, VaxGen deal

...deal, which is expected to close in 1Q10. Two of VaxGen's directors, Lori Rafield and Franklin Berger...
BioCentury | Jan 5, 2009
Finance

2009 Financial Markets Preview: Weathering (nuclear)winter

...deals. "All the debt deals are in the rear view mirror - they're done," said Franklin Berger...
Items per page:
1 - 10 of 92